News

Published on 6 May 2022 on Market Watch

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors


Article preview image

Shares of West Pharmaceutical Services Inc. slid 2.68% to $306.34 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.57% to 4,123.34 and Dow Jones Industrial Average falling 0.30% to 32,899.37. This was the stock's second consecutive day of losses. West Pharmaceutical Services Inc. closed $169.01 short of its 52-week high ($475.35), which the company reached on September 9th.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson fell 0.22% to $176.37, Medtronic PLC fell 1.05% to $103.45, and Stryker Corp. fell 0.53% to $240.08. Trading volume (593,510) eclipsed its 50-day average volume of 419,906.

NYSE.WST price evolution
NYSE.MDT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Medtronic PLC (MDT) is Attracting Investor Attention: Here is What You Should Know

Medtronic (MDT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...

Zacks via Yahoo Finance 12 Apr 2024

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

Medtronic plc MDT recently presented positive clinical trial safety and efficacy results for Sphe...

Zacks via Yahoo Finance 11 Apr 2024

With 85% institutional ownership, Medtronic plc (NYSE:MDT) is a favorite amongst the big guns

Key Insights Institutions' substantial holdings in Medtronic implies that they have significant i...

Simply Wall St. via Yahoo Finance 10 Apr 2024

This weight-loss ETF has performed well in its first five months. How does it compare with cheaper...

With limited market penetration for GLP-1 drugs, investors may still have an early opportunity fo...

MarketWatch via Yahoo Finance 10 Apr 2024

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You ...

Zacks via Yahoo Finance 3 Apr 2024

Medtronic's (MDT) Newest Evolut TAVR System Gets FDA Approval

Medtronic plc MDT recently secured the FDA’s approval for the Evolut FX+ transcatheter aortic val...

Zacks via Yahoo Finance 1 Apr 2024

Medtronic stock gains on FDA OK for Evolut FX (NYSE:MDT)

Medtronic (MDT) stock gained after FDA approved its Evolut FX+ transcatheter aortic valve...

Seeking Alpha 27 Mar 2024

Why Is Medtronic Stock Trading Higher On Wednesday? - Medtronic (NYSE:MDT)

Wednesday, the FDA approved Medtronic plc’s MDT Evolut FX+ transcatheter aortic valve replacement...

Benzinga 27 Mar 2024

14 Best Medical Device Stocks To Buy Now

In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now. You can skip our d...

Insider Monkey via Yahoo Finance 24 Mar 2024

Investors in Medtronic (NYSE:MDT) have unfortunately lost 23% over the last three years

As an investor its worth striving to ensure your overall portfolio beats the market average. But ...

Simply Wall St. via Yahoo Finance 24 Mar 2024